Research map: Chemoradiotherapy intensification in rectal cancer: lessons from the ARISTOTLE trial

Back to the article

Papers in this map

  1. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial · Thierry Conroy · 2024 · 229 citations · Cited by this paper
  2. Consensus statements from the first Gynecologic Cancer InterGroup Cervical Cancer Consensus Conference in Clinical Research · 2026 · Related
  3. Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up · Ralf‐Dieter Hofheinz · 2025 · 192 citations · Cited by this paper
  4. A step forward for precision oncology in thyroid cancer · 2026 · Related
  5. Management of Locally Advanced Rectal Cancer: ASCO Guideline · Aaron James Scott · 2024 · 181 citations · Cited by this paper
  6. RCP calls for UK to recognise air pollution as a public health emergency · 2026 · Related
  7. Future direction of total neoadjuvant therapy for locally advanced rectal cancer · Yoshinori Kagawa · 2024 · 80 citations · Cited by this paper
  8. French MPs vote for sharp cuts in cadmium content in fertilisers · 2026 · Related
  9. Preoperative Chemoradiotherapy Using Concurrent Capecitabine and Irinotecan in Magnetic Resonance Imaging–Defined Locally Advanced Rectal Cancer: Impact on Long-Term Clinical Outcomes · Simon Gollins · 2011 · 55 citations · Cited by this paper
  10. The intermediate-risk gap in AI-based breast cancer stratification · 2026 · Related
  11. A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study · Rob Glynne‐Jones · 2007 · 55 citations · Cited by this paper
  12. Perioperative systemic therapy versus surgery alone for resectable colorectal peritoneal-only metastases (CAIRO6): a randomised, open-label, phase 3 trial · 2026 · Related
  13. Alliance A022104/NRG-GI010: The Janus Rectal Cancer Trial: a randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer · Janet A. Alvarez · 2024 · 45 citations · Cited by this paper
  14. Gastric cancer with peritoneal metastases: hype or hope for HIPEC? · 2026 · Related
  15. Preoperative Chemoradiation With Irinotecan and Capecitabine in Patients With Locally Advanced Resectable Rectal Cancer: Long-Term Results of a Phase II Study · Yong Sang Hong · 2010 · 44 citations · Cited by this paper
  16. Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS) · 2026 · Related
  17. Early Efficacy End Points in Neoadjuvant Rectal Cancer Trials: Surrogacy Revisited · Emmanouil Fokas · 2023 · 10 citations · Cited by this paper
  18. Development and validation of artificial intelligence-assisted volumetric response criteria in pleural mesothelioma (ARTIMES): a retrospective, multicohort, multicentre study · 2026 · Related
  19. Addition of irinotecan to chemoradiotherapy as preoperative treatment for locally advanced rectal cancer (ARISTOTLE): a multicentre, open-label, phase 3, randomised controlled trial · David Sebag‐Montefiore · 2026 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)